324 related articles for article (PubMed ID: 28273362)
1. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
Li B; Sun R; Wei H; Gao B; Tian Z
Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury.
Melin N; Sánchez-Taltavull D; Fahrner R; Keogh A; Dosch M; Büchi I; Zimmer Y; Medová M; Beldi G; Aebersold DM; Candinas D; Stroka D
Cell Death Dis; 2021 Apr; 12(4):366. PubMed ID: 33824326
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 5-mediated signaling enhances liver regeneration in mice.
Zhang W; Wang L; Sun XH; Liu X; Xiao Y; Zhang J; Wang T; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Ren GM; Yin RH; Yang XM
Mil Med Res; 2021 Feb; 8(1):16. PubMed ID: 33622404
[TBL] [Abstract][Full Text] [Related]
5. CD36 deficiency attenuates immune-mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10.
Xu C; Zhang C; Ji J; Wang C; Yang J; Geng B; Zhao T; Zhou H; Mu X; Pan J; Hu S; Lv Y; Chen X; Wen H; You Q
Hepatology; 2018 May; 67(5):1943-1955. PubMed ID: 29220536
[TBL] [Abstract][Full Text] [Related]
6. Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
Burdelya LG; Brackett CM; Kojouharov B; Gitlin II; Leonova KI; Gleiberman AS; Aygun-Sunar S; Veith J; Johnson C; Haderski GJ; Stanhope-Baker P; Allamaneni S; Skitzki J; Zeng M; Martsen E; Medvedev A; Scheblyakov D; Artemicheva NM; Logunov DY; Gintsburg AL; Naroditsky BS; Makarov SS; Gudkov AV
Proc Natl Acad Sci U S A; 2013 May; 110(20):E1857-66. PubMed ID: 23630282
[TBL] [Abstract][Full Text] [Related]
7. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
Ren J; Meng S; Yan B; Yu J; Liu J
Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
[TBL] [Abstract][Full Text] [Related]
8. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.
Fullerton AM; Roth RA; Ganey PE
Toxicol Sci; 2013 Nov; 136(1):72-85. PubMed ID: 23970800
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-- mediated immune hepatic injury.
Tsai CC; Huang WC; Chen CL; Hsieh CY; Lin YS; Chen SH; Yang KC; Lin CF
J Immunol; 2011 Oct; 187(7):3867-77. PubMed ID: 21873526
[TBL] [Abstract][Full Text] [Related]
11. CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production.
Chen Y; Peng H; Chen Y; Wei H; Sun R; Tian Z
Immunology; 2014 Mar; 141(3):388-400. PubMed ID: 24164540
[TBL] [Abstract][Full Text] [Related]
12. Scavenger receptor A restrains T-cell activation and protects against concanavalin A-induced hepatic injury.
Zuo D; Yu X; Guo C; Wang H; Qian J; Yi H; Lu X; Lv ZP; Subjeck JR; Zhou H; Sanyal AJ; Chen Z; Wang XY
Hepatology; 2013 Jan; 57(1):228-38. PubMed ID: 22821642
[TBL] [Abstract][Full Text] [Related]
13. Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice.
Al Dulaimi D; Klibi J; Olivo Pimentel V; Parietti V; Allez M; Toubert A; Benlagha K
Front Immunol; 2018; 9():1052. PubMed ID: 29868013
[TBL] [Abstract][Full Text] [Related]
14. PARP2 deficiency affects invariant-NKT-cell maturation and protects mice from concanavalin A-induced liver injury.
Filliol A; Piquet-Pellorce C; Dion S; Genet V; Lucas-Clerc C; Dantzer F; Samson M
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G399-G409. PubMed ID: 28751426
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin protects against concanavalin A-induced liver injury in mice.
Yin H; Cheng L; Agarwal C; Agarwal R; Ju C
Liver Int; 2010 Apr; 30(4):623-32. PubMed ID: 20136718
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice.
Volarevic V; Milovanovic M; Ljujic B; Pejnovic N; Arsenijevic N; Nilsson U; Leffler H; Lukic ML
Hepatology; 2012 Jun; 55(6):1954-64. PubMed ID: 22213244
[TBL] [Abstract][Full Text] [Related]
18. Protective role of IL-33/ST2 axis in Con A-induced hepatitis.
Volarevic V; Mitrovic M; Milovanovic M; Zelen I; Nikolic I; Mitrovic S; Pejnovic N; Arsenijevic N; Lukic ML
J Hepatol; 2012 Jan; 56(1):26-33. PubMed ID: 21703183
[TBL] [Abstract][Full Text] [Related]
19. Paeoniflorin protects against concanavalin A-induced hepatitis in mice.
Chen M; Cao L; Luo Y; Feng X; Sun L; Wen M; Peng S
Int Immunopharmacol; 2015 Jan; 24(1):42-9. PubMed ID: 25479726
[TBL] [Abstract][Full Text] [Related]
20. The Role of Serotonin in Concanavalin A-Induced Liver Injury in Mice.
Pang Q; Jin H; Ke X; Man Z; Wang Y; Tan Y; Lu Z; Liu H
Oxid Med Cell Longev; 2020; 2020():7504521. PubMed ID: 31998441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
